Valuables | Group A (n = 110) | Group B (n = 90) | P value |
---|---|---|---|
Follow-up time (months) | 95.9 ± 22.7 | 91.2 ± 20.8 | 0.130 |
Cerebral hemorrhage (%) | 0 (0.0) | 3 (3.3) | 0.191 |
Cerebral infarction (%) | 0 (0.0) | 1 (1.1) | 0.948 |
Gastrointestinal hemorrhage (%) | 1 (0.9) | 4 (4.4) | 0.268 |
AR (moderate or above) (%) | 2 (1.8) | 0 (0.0) | 0.590 |
Perivalvular leakage (%) | 0 (0.0) | 1 (1.1) | 0.948 |
Biological valve aging (%) | 0 (0.0) | 0 (0.0) | N/A |
Infection (%) | 1 (0.9) | 2 (2.2) | 0.879 |
Mechanical disturbance of the valve (%) | 0 (0.0) | 3 (3.3) | 0.191 |
endoleakage (%) | 0 (0.0) | 6 (6.7) | 0.022 |
Anticoagulation-related thromboembolism/bleeding events* (%) | 0 (0.0) | 10 (11.1) | 0.001 |
Postoperative aortic valve re-operation (%) | 1 (0.9) | 8 (8.9) | 0.020 |